Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk. [PDF]
Vahldieck C, Fels B.
europepmc +1 more source
The study employed a four‐tiered strategy: (1) UHPLC‐FTMS profiling of Citrus aurantium honey to characterize its chemical composition; (2) network pharmacology analysis integrating target prediction, protein–protein interaction networks, and KEGG pathway enrichment to identify the Thor1/Nprl2‐TORC1 axis as a key mechanistic pathway; (3) in vitro ...
Wenqi Wan +6 more
wiley +1 more source
Inhibition of Complement Will Substantially Reduce the Anemia of Malaria. [PDF]
Taylor RP, Lindorfer MA.
europepmc +1 more source
Relapses, Comorbidities, and Predictors of Outcome in Anti‐GABAA Receptor Encephalitis
Objectives To characterize the magnetic resonance imaging (MRI) lesion dynamics, comorbidities, predictors of relapse, and outcomes in anti‐γ‐aminobutyric acid type A receptor (GABAAR) encephalitis, and assess the utility of LIM‐domain‐only‐protein 5 (LMO5) antibodies as tumor markers.
Claudia Papi +33 more
wiley +1 more source
Dual roles of complement in ulcerative colitis: insights from clinical studies and animal research. [PDF]
Qin Z, Wang R, Zhang Y.
europepmc +1 more source
Plant Virus Immunotherapy for HPV‐Associated Oropharyngeal Squamous Cell Carcinoma
Cowpea mosaic virus (CPMV) nanoparticles are safe and potent cancer immunotherapy candidates with strong immunomodulatory activity. CPMV activates innate immunity, which in turn drives adaptive immune responses and promotes durable, systemic antitumor effects.
Jessica Fernanda Affonso de Oliveira +7 more
wiley +1 more source
Redox Regulation of Complement Pathway Activation in Aging and Related Diseases. [PDF]
Ferdowsi S, Arjuna S, Sj S, Zennadi R.
europepmc +1 more source
Baicalin ameliorates podocyte injury and renal function impairment in idiopathic membranous nephropathy by inhibiting the AGE/RAGE signaling. [PDF]
Lou C +6 more
europepmc +1 more source
Salvaging sepsis-associated atypical hemolytic uremic syndrome with terminal complement blockade: A case report. [PDF]
Qiu Y +5 more
europepmc +1 more source
Sustained remission with eculizumab in refractory lupus nephritis with atypical haemolytic uraemic syndrome. [PDF]
Thomson B, Nicholls K.
europepmc +1 more source

